Structure Therapeutics Inc.
GPCR· Nasdaq
Structure Therapeutics Inc.
- Last sale
- Oct 1, 2026 · -7.08%
- Market cap
- $6.20B
- 213.93M shares
- Filings
- 270
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $225,255,000 | reported | |
| FY 2024 | 2024-12-31 | $108,814,000 | reported | |
| FY 2023 | 2023-12-31 | $70,103,000 | reported | |
| FY 2022 | 2022-12-31 | $36,193,000 | reported |
Structure Therapeutics Inc. · CIK 1888886 · Engraved from SEC EDGAR
